Indivior Reaches Agreement with Direct Purchasers to Resolve Antitrust Multi-District Litigation
The agreement with the direct purchasers will mark the conclusion of the MDL, once the settlements for the…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
24 Oct 23
The agreement with the direct purchasers will mark the conclusion of the MDL, once the settlements for the…
20 Oct 23
The European Commission has unconditionally approved the transaction, concluding that the proposed transaction would not significantly reduce competition…
20 Oct 23
The expansion project, part of the global investment plans announced in 2022, includes construction of a new extensive…
20 Oct 23
The deal includes Daiichi Sankyo’s patritumab deruxtecan (HER3-DXd), ifinatamab deruxtecan (I-DXd) and raludotatug deruxtecan (R-DXd) candidates
20 Oct 23
The study is intended to assess the effect of diet quality, food characteristics and lifestyle factors on participants’…
20 Oct 23
Within the framework of the collaboration, Mayo Clinic and Oxford Nanopore have identified several key areas of development,…
20 Oct 23
The Phase I trial is designed as a multi-center, randomized, double-blind, placebo-controlled study to investigate the safety, tolerability,…
20 Oct 23
Aspen plans to initiate a first-in-patient Phase 1/2a clinical trial of ANPD001 for participants with moderate to severe…
19 Oct 23
Adcetris is an antibody-drug conjugate (ADC) with an anti-CD30 antibody, which in combination with doxorubicin, vinblastine and dacarbazine…
19 Oct 23
Stuart Therapeutics will get an upfront payment as well as development and sales-related milestone payments along with royalties…